Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever

J. L. McClellan, J. J. Klir, L. E. Morrow, M. J. Kluger

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Intracerebroventricular administration of the glucocorticoid type II receptor antagonist RU-38486 leads to an increased fever after injection of lipopolysaccharide (LPS) in awake unrestrained rats, indicating that endogenous glucocorticoids act centrally to lower temperature after the intraperitoneal injection of LPS. The current study examined where in the brain glucocorticoids exert these effects on fever and if these effects involve plasma interleukin-6 and corticosterone. RU-38486 injected intracerebroventricularly (10 ng/animal) led to a significantly greater rise in biotelemetered body temperature (BT) 120-240 min post-LPS (50 mg/kg ip) compared with controls (0.89 ± 0.14 vs. 0.44 ± 0.22°C, P = 0.0482), confirming our earlier study, and also led to a significantly greater rise in BT after exposure to an open field when the RU-38486 was infused intracerebroventricularly (10 ng/ml, 1 μl/h) for 20 h before the exposure (1.48 ± 0.18 vs. 1.06 ± 0.11°C, P = 0.023). When rats were injected with RU-38486 into the anterior hypothalamus (1 ng/animal), there was an increased rise in BT after injection of LPS (1.74 ± 0.27 vs. 0.82 ± 0.22°C, P = 0.0075) but not after exposure to an open field (1 ng intrahypothalamically, 1 h preexposure). There were no differences in plasma interleukin (IL)-6- like activity or plasma corticosterone after intracerebroventricular injection of RU-38486 and intraperitoneal injection of LPS. We conclude that endogenous glucocorticoids are working centrally to modulate fever after LPS and exposure to open field, and that LPS-induced fever is modulated by glucocorticoids in the anterior hypothalamus. The precise location of glucocorticoid negative feedback on psychological stress-induced fever is not known.

Original languageEnglish (US)
Pages (from-to)R705-R711
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume267
Issue number3 36-3
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Mifepristone
Glucocorticoid Receptors
Lipopolysaccharides
Fever
Glucocorticoids
Body Temperature
Anterior Hypothalamus
Corticosterone
Intraperitoneal Injections
Injections
Interleukin-6
Psychological Stress
Temperature
Brain

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever. / McClellan, J. L.; Klir, J. J.; Morrow, L. E.; Kluger, M. J.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 267, No. 3 36-3, 01.01.1994, p. R705-R711.

Research output: Contribution to journalArticle

@article{1e80f528edbc442fab844f26c7a982d9,
title = "Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever",
abstract = "Intracerebroventricular administration of the glucocorticoid type II receptor antagonist RU-38486 leads to an increased fever after injection of lipopolysaccharide (LPS) in awake unrestrained rats, indicating that endogenous glucocorticoids act centrally to lower temperature after the intraperitoneal injection of LPS. The current study examined where in the brain glucocorticoids exert these effects on fever and if these effects involve plasma interleukin-6 and corticosterone. RU-38486 injected intracerebroventricularly (10 ng/animal) led to a significantly greater rise in biotelemetered body temperature (BT) 120-240 min post-LPS (50 mg/kg ip) compared with controls (0.89 ± 0.14 vs. 0.44 ± 0.22°C, P = 0.0482), confirming our earlier study, and also led to a significantly greater rise in BT after exposure to an open field when the RU-38486 was infused intracerebroventricularly (10 ng/ml, 1 μl/h) for 20 h before the exposure (1.48 ± 0.18 vs. 1.06 ± 0.11°C, P = 0.023). When rats were injected with RU-38486 into the anterior hypothalamus (1 ng/animal), there was an increased rise in BT after injection of LPS (1.74 ± 0.27 vs. 0.82 ± 0.22°C, P = 0.0075) but not after exposure to an open field (1 ng intrahypothalamically, 1 h preexposure). There were no differences in plasma interleukin (IL)-6- like activity or plasma corticosterone after intracerebroventricular injection of RU-38486 and intraperitoneal injection of LPS. We conclude that endogenous glucocorticoids are working centrally to modulate fever after LPS and exposure to open field, and that LPS-induced fever is modulated by glucocorticoids in the anterior hypothalamus. The precise location of glucocorticoid negative feedback on psychological stress-induced fever is not known.",
author = "McClellan, {J. L.} and Klir, {J. J.} and Morrow, {L. E.} and Kluger, {M. J.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "267",
pages = "R705--R711",
journal = "American Journal of Physiology - Regulatory Integrative and Comparative Physiology",
issn = "0363-6119",
publisher = "American Physiological Society",
number = "3 36-3",

}

TY - JOUR

T1 - Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever

AU - McClellan, J. L.

AU - Klir, J. J.

AU - Morrow, L. E.

AU - Kluger, M. J.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Intracerebroventricular administration of the glucocorticoid type II receptor antagonist RU-38486 leads to an increased fever after injection of lipopolysaccharide (LPS) in awake unrestrained rats, indicating that endogenous glucocorticoids act centrally to lower temperature after the intraperitoneal injection of LPS. The current study examined where in the brain glucocorticoids exert these effects on fever and if these effects involve plasma interleukin-6 and corticosterone. RU-38486 injected intracerebroventricularly (10 ng/animal) led to a significantly greater rise in biotelemetered body temperature (BT) 120-240 min post-LPS (50 mg/kg ip) compared with controls (0.89 ± 0.14 vs. 0.44 ± 0.22°C, P = 0.0482), confirming our earlier study, and also led to a significantly greater rise in BT after exposure to an open field when the RU-38486 was infused intracerebroventricularly (10 ng/ml, 1 μl/h) for 20 h before the exposure (1.48 ± 0.18 vs. 1.06 ± 0.11°C, P = 0.023). When rats were injected with RU-38486 into the anterior hypothalamus (1 ng/animal), there was an increased rise in BT after injection of LPS (1.74 ± 0.27 vs. 0.82 ± 0.22°C, P = 0.0075) but not after exposure to an open field (1 ng intrahypothalamically, 1 h preexposure). There were no differences in plasma interleukin (IL)-6- like activity or plasma corticosterone after intracerebroventricular injection of RU-38486 and intraperitoneal injection of LPS. We conclude that endogenous glucocorticoids are working centrally to modulate fever after LPS and exposure to open field, and that LPS-induced fever is modulated by glucocorticoids in the anterior hypothalamus. The precise location of glucocorticoid negative feedback on psychological stress-induced fever is not known.

AB - Intracerebroventricular administration of the glucocorticoid type II receptor antagonist RU-38486 leads to an increased fever after injection of lipopolysaccharide (LPS) in awake unrestrained rats, indicating that endogenous glucocorticoids act centrally to lower temperature after the intraperitoneal injection of LPS. The current study examined where in the brain glucocorticoids exert these effects on fever and if these effects involve plasma interleukin-6 and corticosterone. RU-38486 injected intracerebroventricularly (10 ng/animal) led to a significantly greater rise in biotelemetered body temperature (BT) 120-240 min post-LPS (50 mg/kg ip) compared with controls (0.89 ± 0.14 vs. 0.44 ± 0.22°C, P = 0.0482), confirming our earlier study, and also led to a significantly greater rise in BT after exposure to an open field when the RU-38486 was infused intracerebroventricularly (10 ng/ml, 1 μl/h) for 20 h before the exposure (1.48 ± 0.18 vs. 1.06 ± 0.11°C, P = 0.023). When rats were injected with RU-38486 into the anterior hypothalamus (1 ng/animal), there was an increased rise in BT after injection of LPS (1.74 ± 0.27 vs. 0.82 ± 0.22°C, P = 0.0075) but not after exposure to an open field (1 ng intrahypothalamically, 1 h preexposure). There were no differences in plasma interleukin (IL)-6- like activity or plasma corticosterone after intracerebroventricular injection of RU-38486 and intraperitoneal injection of LPS. We conclude that endogenous glucocorticoids are working centrally to modulate fever after LPS and exposure to open field, and that LPS-induced fever is modulated by glucocorticoids in the anterior hypothalamus. The precise location of glucocorticoid negative feedback on psychological stress-induced fever is not known.

UR - http://www.scopus.com/inward/record.url?scp=0028087692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028087692&partnerID=8YFLogxK

M3 - Article

C2 - 8092314

AN - SCOPUS:0028087692

VL - 267

SP - R705-R711

JO - American Journal of Physiology - Regulatory Integrative and Comparative Physiology

JF - American Journal of Physiology - Regulatory Integrative and Comparative Physiology

SN - 0363-6119

IS - 3 36-3

ER -